cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]
- RxCUI
- 402092
- RxNorm name
- cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]
- Display name
- cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]
- Full name
- cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Restasis MultiDose | CYCLOSPORINE | Allergan, Inc. | 7224d810-bb96-4682-a942-3355e6e8061a | 2025-08-21 | Warnings, Adverse reactions | 402092 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7224d810-bb96-4682-a942-3355e6e8061a | Restasis 0.05 % Ophthalmic Emulsion [PSN] · cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis] [SBD] · Restasis 0.05 % Ophthalmic Emulsion [SY] · Restasis 0.05 % Ophthalmic Suspension [SY] · Restasis 0.5 MG/ML Ophthalmic Suspension [SY] | 5 | 15 | These highlights do not include all the information needed to use RESTASIS MULTIDOSE safely and effectively. See full prescribing information for RESTASIS MULTIDOSE . RESTASIS MULTIDOSE ® ( cyclosporine ophthalmic emulsion ) 0.05% , f or topical ophthalmic use Initial U.S. Approval: 1983 | 20250821 |